| atezolizumab based treatment |
| atezolizumab plus carboplatin plus nab-paclitaxel | atezolizumab plus nab-paclitxel followed by doxorubicin plus cyclophosphamide |
es-BC - Triple negatif (TNBC) - (neo)adjuvant (NA) | | |
es-BC - TNBC - NA - all population 5 | | |
es-BC - TNBC - NA - PDL1 positive 1 | | |